Literature DB >> 30115542

Human apolipoprotein A-I Gly26Arg stimulation of inflammatory responses via NF-kB activation: Potential roles in amyloidosis?

Nahuel A Ramella1, Isabel Andújar2, José L Ríos3, Silvana A Rosú1, M Alejandra Tricerri4, Guillermo R Schinella5.   

Abstract

The cascade of molecular events leading to Human apolipoprotein A-I (apoA-I) amyloidosis is not completely understood, not even the pathways that determine clinical manifestations associated to systemic protein deposition in organs such as liver, kidney and heart. About twenty natural variants of apoA-I were described as inducing amyloidosis, but the mechanisms driving their aggregation and deposition are still unclear. We previously identified that the mutant Gly26Arg but not Lys107-0 induced the release of cytokines and reactive oxygen species from cultured RAW 264.7 murine macrophages, suggesting that part of the pathogenic pathway could elicit of an inflammatory signal. In this work we gained deep insight into this mechanism and determined that Gly26Arg induced a specific pro-inflammatory cascade involving activation of NF-κB and its translocation into the nucleus. These findings suggest that some but not all apoA-I natural variants might promote a pro-oxidant microenvironment which could in turn result in oxidative processing of the variants into a misfolded conformation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloidosis; Apolipoprotein A-I variants; Inflammation; Macrophages activation; Nuclear factor-κB

Year:  2018        PMID: 30115542     DOI: 10.1016/j.pathophys.2018.08.002

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  1 in total

1.  Role of Apolipoprotein A1 in PPAR Signaling Pathway for Nonalcoholic Fatty Liver Disease.

Authors:  Changxi Chen; Hongliang Li; Jian Song; Cheng Zhang; Mengting Li; Yushan Mao; Aiming Liu; Juan Du
Journal:  PPAR Res       Date:  2022-02-18       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.